相关实验视频
Updated: May 5, 2026

09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
28.4K
工程外体膜伪装的热响应系统用于向药物输送和通过血脑屏障控制释放的药物
Zhe Han1,2,3, Haina Huang4, Boyan Li1,2,3
1Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Ji'nan, Shandong, 250012, China.
Materials today. Bio
|March 31, 2025
概括
这项研究引入了一种新的纳米载体系统,可以穿越血脑屏障来治疗脑瘤. 它使用光热和光催化纳米粒子释放化疗药物并提高治疗效率.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 血脑屏障 (BBB) 阻碍了化疗药物输送到脑瘤,导致抗药性和不良结果.
- 瘤缺氧加剧了这些挑战,需要先进的治疗策略.
研究的目的:
- 开发一种热敏纳米载体系统,用于增强脑瘤化疗.
- 为了克服BBB的局限性,并改善瘤部位的药物度.
主要方法:
- 合成了具有光热和光催化性能的复合Ru/Pt-TiOx纳米粒子.
- doxorubicin (DOX) 被纳入一个相变材料,并与纳米粒子 (RPTiOx-DOX) 结合.
- 纳米颗粒与angiopep-2-修改的巨细胞外体膜功能化,以穿越BBB.
主要成果:
- 纳米载体系统有效地穿越了BBB,并在近红外辐射下释放了DOX.
- 光催化产生氧气,减少缺氧诱导的因素和药物排放.
- 巨细胞的表型转换 (M2→M1) 和免疫调节有助于抑制瘤生长.
结论:
- 开发了一种能够透BBB和产生协同作用的抗瘤作用的新型药物输送系统.
- 该系统为用于脑瘤的刺激反应复合纳米粒子药物配方提供了创新的见解.
相关概念视频
The Blood-brain Barrier
47.4K
Overview
47.4K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165

